Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Badran

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
Current Drug Delivery|February 20, 2020
Cholesterol-Conjugate as a New Strategy to Improve the Cytotoxic Effect of 5-Fluorouracil on Liver Cancer: Impact of Liposomal CompositionSaleh Ayed Alanazi, Gamaleldin Ibrahim Harisa, Mohammad M Badran, et al.
Current Pharmaceutical Biotechnology|July 1, 2026
Comparative Phytochemical Characterization and Antibacterial Activity of Ethanol and Aqueous Extracts of Moringa peregrina and Moringa oleifera against Multidrug-Resistant BacteriaMaha S I Wizrah, Zeinab A Yahia, Samah Awad AbduRahim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2005
Transcriptional regulation of the human CD3 gamma gene: the TATA-less CD3 gamma promoter functions via an initiator and contiguous Sp-binding elementsBassam M Badran, Kevin Kunstman, Jennifer Stanton, et al.
Current Drug Delivery|July 20, 2020
Cytotoxicity of Chitosan Ultrafine Nanoshuttles on the MCF-7 Cell Line as a Surrogate Model for Breast CancerTarek Faris, Gamaleldin I Harisa, Fars K Alanazi, et al.
Leukemia|February 9, 2007
HTLV-I infection of WE17/10 CD4+ cell line leads to progressive alteration of Ca2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformationH Akl, B M Badran, N El Zein, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2005
Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapyAbdel-Rahman El-Zayadi, Mohy Attia, Hanaa M Badran, et al.
The British Journal of Nutrition|August 23, 2006
Taurine status and response to intravenous taurine supplementation in adults with short-bowel syndrome undergoing long-term parenteral nutrition: a pilot studyStéphane M Schneider, Françoise Joly, Marie-France Gehrardt, et al.
Artificial Cells, Nanomedicine, and Biotechnology|March 16, 2019
Nano-erythrocyte membrane-chaperoned 5-fluorouracil liposomes as biomimetic delivery platforms to target hepatocellular carcinoma cell linesSaeed A AlQahtani, Gamaleldin I Harisa, Mohamed M Badran, et al.
Polymers|August 10, 2024
Polycaprolactone-Vitamin E TPGS Micellar Formulation for Oral Delivery of PaclitaxelZiyad Binkhathlan, Raisuddin Ali, Osman Yusuf, et al.
World Journal of Gastroenterology|August 30, 2005
Hepatocellular carcinoma in Egypt: a single center study over a decadeAbdel-Rahman el-Zayadi, Hanaa M Badran, Eman M F Barakat, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Current Drug Delivery|February 20, 2020
Cholesterol-Conjugate as a New Strategy to Improve the Cytotoxic Effect of 5-Fluorouracil on Liver Cancer: Impact of Liposomal CompositionSaleh Ayed Alanazi, Gamaleldin Ibrahim Harisa, Mohammad M Badran, et al.
Current Pharmaceutical Biotechnology|July 1, 2026
Comparative Phytochemical Characterization and Antibacterial Activity of Ethanol and Aqueous Extracts of Moringa peregrina and Moringa oleifera against Multidrug-Resistant BacteriaMaha S I Wizrah, Zeinab A Yahia, Samah Awad AbduRahim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2005
Transcriptional regulation of the human CD3 gamma gene: the TATA-less CD3 gamma promoter functions via an initiator and contiguous Sp-binding elementsBassam M Badran, Kevin Kunstman, Jennifer Stanton, et al.
Current Drug Delivery|July 20, 2020
Cytotoxicity of Chitosan Ultrafine Nanoshuttles on the MCF-7 Cell Line as a Surrogate Model for Breast CancerTarek Faris, Gamaleldin I Harisa, Fars K Alanazi, et al.
Leukemia|February 9, 2007
HTLV-I infection of WE17/10 CD4+ cell line leads to progressive alteration of Ca2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformationH Akl, B M Badran, N El Zein, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2005
Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapyAbdel-Rahman El-Zayadi, Mohy Attia, Hanaa M Badran, et al.
The British Journal of Nutrition|August 23, 2006
Taurine status and response to intravenous taurine supplementation in adults with short-bowel syndrome undergoing long-term parenteral nutrition: a pilot studyStéphane M Schneider, Françoise Joly, Marie-France Gehrardt, et al.
Artificial Cells, Nanomedicine, and Biotechnology|March 16, 2019
Nano-erythrocyte membrane-chaperoned 5-fluorouracil liposomes as biomimetic delivery platforms to target hepatocellular carcinoma cell linesSaeed A AlQahtani, Gamaleldin I Harisa, Mohamed M Badran, et al.
Polymers|August 10, 2024
Polycaprolactone-Vitamin E TPGS Micellar Formulation for Oral Delivery of PaclitaxelZiyad Binkhathlan, Raisuddin Ali, Osman Yusuf, et al.
World Journal of Gastroenterology|August 30, 2005
Hepatocellular carcinoma in Egypt: a single center study over a decadeAbdel-Rahman el-Zayadi, Hanaa M Badran, Eman M F Barakat, et al.
Pageof 11